BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

164 related articles for article (PubMed ID: 2956405)

  • 1. Effect of bronchodilators on airway resistance in ventilator-dependent neonates with chronic lung disease.
    Wilkie RA; Bryan MH
    J Pediatr; 1987 Aug; 111(2):278-82. PubMed ID: 2956405
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Bronchodilator response to ipratropium bromide in infants with bronchopulmonary dysplasia.
    Brundage KL; Mohsini KG; Froese AB; Fisher JT
    Am Rev Respir Dis; 1990 Nov; 142(5):1137-42. PubMed ID: 2146910
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy and tolerance of high-dose inhaled ipratropium bromide vs. terbutaline in intubated premature human neonates.
    Fayon M; Tayara N; Germain C; Choukroun ML; De La Roque ED; ChĂȘne G; Breilh D; Marthan R; Demarquez JL
    Neonatology; 2007; 91(3):167-73. PubMed ID: 17377401
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Controlled trial of beclomethasone dipropionate by nebulization in oxygen- and ventilator-dependent infants.
    LaForce WR; Brudno DS
    J Pediatr; 1993 Feb; 122(2):285-8. PubMed ID: 8429447
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Respiratory response and pharmacokinetics of intravenous salbutamol in infants with bronchopulmonary dysplasia.
    Kirpalani H; Koren G; Schmidt B; Tan Y; Santos R; Soldin S
    Crit Care Med; 1990 Dec; 18(12):1374-7. PubMed ID: 2173991
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Response to bronchodilators in clinically stable 1-year-old patients with bronchopulmonary dysplasia.
    De Boeck K; Smith J; Van Lierde S; Devlieger H
    Eur J Pediatr; 1998 Jan; 157(1):75-9. PubMed ID: 9461369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparison of salbutamol and ipratropium bromide versus salbutamol alone in the treatment of acute severe asthma.
    Hossain AS; Barua UK; Roy GC; Sutradhar SR; Rahman I; Rahman G
    Mymensingh Med J; 2013 Apr; 22(2):345-52. PubMed ID: 23715360
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bronchodilators and diuretics in children with bronchopulmonary dysplasia.
    Logvinoff MM; Lemen RJ; Taussig LM; Lamont BA
    Pediatr Pulmonol; 1985; 1(4):198-203. PubMed ID: 3840882
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nebulized furosemide in infants with bronchopulmonary dysplasia.
    Rastogi A; Luayon M; Ajayi OA; Pildes RS
    J Pediatr; 1994 Dec; 125(6 Pt 1):976-9. PubMed ID: 7996373
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Bronchodilator aerosol administered by metered dose inhaler and spacer in subacute neonatal respiratory distress syndrome.
    Lee H; Arnon S; Silverman M
    Arch Dis Child Fetal Neonatal Ed; 1994 May; 70(3):F218-22. PubMed ID: 8198418
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Tolerability and efficacy of two doses of aerosolized albuterol in ventilated infants with BPD: A randomized controlled crossover trial.
    Napolitano N; Dysart K; Soorikian L; Zhang H; Panitch H; Jensen E
    Pediatr Pulmonol; 2021 Jan; 56(1):97-104. PubMed ID: 33095509
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bronchodilators for the prevention and treatment of chronic lung disease in preterm infants.
    Ng GY; da S; Ohlsson A
    Cochrane Database Syst Rev; 2001; (3):CD003214. PubMed ID: 11687053
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Increased compliance in response to salbutamol in premature infants with developing bronchopulmonary dysplasia.
    Rotschild A; Solimano A; Puterman M; Smyth J; Sharma A; Albersheim S
    J Pediatr; 1989 Dec; 115(6):984-91. PubMed ID: 2685221
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Dexamethasone therapy for bronchopulmonary dysplasia: improved respiratory mechanics without adrenal suppression.
    Brundage KL; Mohsini KG; Froese AB; Walker CR; Fisher JT
    Pediatr Pulmonol; 1992 Mar; 12(3):162-9. PubMed ID: 1641273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Efficacy of nebulized ipratropium bromide versus salbutamol in infants with acute bronchiolities.
    Absar SM; Jahan S; Khanum S
    Bangladesh Med Res Counc Bull; 2008 Dec; 34(3):112. PubMed ID: 19476260
    [No Abstract]   [Full Text] [Related]  

  • 16. [Physiological basis for the use of muscarine antagonists in bronchopulmonary dysplasia].
    Fisher JT; Froese AB; Brundage KL
    Arch Pediatr; 1995; 2 Suppl 2():163S-171S. PubMed ID: 7633558
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Bronchodilator effects of clemastine, ipratropium, bromide, and salbutamol in preschool children with asthma.
    Groggins RC; Milner AD; Stokes GM
    Arch Dis Child; 1981 May; 56(5):342-4. PubMed ID: 6455096
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Thermogenic effect of bronchodilators in patients with chronic obstructive pulmonary disease.
    Burdet L; de Muralt B; Schutz Y; Fitting JW
    Thorax; 1997 Feb; 52(2):130-5. PubMed ID: 9059472
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Use of anticholinergic bronchodilation in children.
    Rubin BK; Albers GM
    Am J Med; 1996 Jan; 100(1A):49S-53S. PubMed ID: 8610717
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Early onset of airway reactivity in premature infants with bronchopulmonary dysplasia.
    Motoyama EK; Fort MD; Klesh KW; Mutich RL; Guthrie RD
    Am Rev Respir Dis; 1987 Jul; 136(1):50-7. PubMed ID: 3605840
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.